Regenerative Medicine Breakout, KI-Mayo Meeting 2022
Program Chairs and Moderators: Ewa Ellis, Karolinska Institutet, Roberto Gramignoli, Karolinska Institutet, David Lott,Mayo Clinic and Anthony Windebank, Mayo Clinic
Regenerative Medicine Breakout Session
15:30- 17:35 PM (Stockholm); 8:30- 10:35 AM (Rochester)
Welcome and Overview of Session Day One
- 15:30pm/8:30am: Optimizing the in vitro production of immunomodulatory cells for the induction of tolerance. - Nils Ågren, Karolinska Institutet
- 15:45pm/8:45am: Regenerative Medicine: It’s Time We Start Thinking About Infectious Disease. - Christopher F. Saling, Mayo Clinic
- 16:00pm/9:00 am: Target-directed microRNA degradation in human skin wound healing. - Letian Zhang, Karolinska Institutet
- 16:15pm/9:15am: Perinatal amniotic epithelial cells in support to pancreatic islet transplantation. - Dimitri Van Simaeys, Karolinska Institutet
- 16:30pm/9:30am: Preliminary results with hypothermic oxygenated liver perfusion. - Antonio Romano, Karolinska Institutet
- 16:50pm/9:50am: TBC. - Amit Mathur, Jack Harbell, Michelle Nguyen, Mayo Clinic
- 17:30pm/10:30am: Adjourn
16:15- 18:20 PM (Stockholm); 9:15 - 11:00 AM (Rochester)
Welcome and Overview of Session Day Two
- 16:15pm/09:15am: Increased risk of cardiac arrythmia in Hailey-Hailey disease in a population-based cohort: first evidence of extra-cutaneous comorbidity - William Jebril, Karolinska Institutet
- 16:30pm/09:30am: Evaluation of Diced Cartilage for Nasal Reconstruction - Daniah ALNafisee, Mayo Clinic
- 16:55pm/09:45am: Wnt/β-catenin and NFκB signaling synergize to trigger growth-factor-free regeneration of adult primary human hepatocytes - Nuria Oliva-Vilarnau, Karolinska Institutet
- 17:00pm/10:00am: Diversity of Form and Function in Mouse Intestinal Intrinsic Primary Afferent Neurons - David Linden, Mayo Clinic
- 17:15pm/10:15am: Human perinatal stem cells reduce disease progression in mouse model for multiple sclerosis - Heela Sarlus, Karolinska Institutet
- 17:30pm/10:30am: Utilizing adeno-associated virus serotype 2.5 for gene therapy targeting CNS and PNS tissues - Ahad Siddiqui (online), Mayo Clinic
- 17:45pm/10:45am: Bedside leukapheresis prior to organ procurement is a safe and feasible method of obtaining PBMCs from deceased donors for tolerance-induction protocols - Ming Yao, Karolinska Institutet
- 18:00pm/11:00am: Developing Genome Editing for Spinal Cord Injury Repair. Nicolas Madigan, Mayo Clinic
- 18:15pm/11:15am: Adjourn
- 18:20pm/11:20 am Transition to Fika
- 18:30pm/11:30 am Plenary begins